Editas Medicine Stock Price on February 14, 2022

EDIT Stock  USD 7.44  0.22  3.05%   
Below is the normalized historical share price chart for Editas Medicine extending back to February 03, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Editas Medicine stands at 7.44, as last reported on the 28th of March, with the highest price reaching 7.53 and the lowest price hitting 7.19 during the day.
IPO Date
3rd of February 2016
200 Day MA
8.594
50 Day MA
8.1518
Beta
2.052
 
Yuan Drop
 
Covid
If you're considering investing in Editas Stock, it is important to understand the factors that can impact its price. Editas Medicine secures Sharpe Ratio (or Efficiency) of -0.0739, which denotes the company had a -0.0739% return per unit of risk over the last 3 months. Editas Medicine exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Editas Medicine's Variance of 25.08, standard deviation of 5.01, and Mean Deviation of 3.39 to check the risk estimate we provide.
  
At this time, Editas Medicine's Other Stockholder Equity is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 23.5 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 239.8 M in 2024. . At this time, Editas Medicine's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.31 in 2024, whereas Price Earnings To Growth Ratio is likely to drop 0.15 in 2024. Editas Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0739

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsEDIT

Estimated Market Risk

 5.15
  actual daily
45
55% of assets are more volatile

Expected Return

 -0.38
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Editas Medicine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Editas Medicine by adding Editas Medicine to a well-diversified portfolio.
Price Book
1.6921
Enterprise Value Ebitda
(1.86)
Price Sales
7.8072
Shares Float
73.9 M
Wall Street Target Price
15.86

Editas Medicine Valuation on February 14, 2022

It is possible to determine the worth of Editas Medicine on a given historical date. On February 14, 2022 Editas was worth 15.01 at the beginning of the trading date compared to the closed value of 14.08. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Editas Medicine stock. Still, in general, we apply an absolute valuation method to find Editas Medicine's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Editas Medicine where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Editas Medicine's related companies.
 Open High Low Close Volume
03/14/2022
  15.01    15.46    13.87    14.08    2,113,000  
  14.12    14.96    13.95    14.91    1,274,000  
Backtest Editas Medicine  |  Editas Medicine History  |  Editas Medicine Valuation Next  
Open Value
15.01
14.08
Closing Value
30.47
Upside

Editas Medicine Trading Date Momentum on February 14, 2022

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Editas Medicine Fundamentals Correlations and Trends

By evaluating Editas Medicine's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Editas Medicine's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Editas financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Editas Medicine Stock history

Editas Medicine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Editas is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Editas Medicine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Editas Medicine stock prices may prove useful in developing a viable investing in Editas Medicine
Last ReportedProjected for 2024
Common Stock Shares Outstanding76 M49.3 M
Net Loss-198.4 M-188.5 M

Editas Medicine Quarterly Net Working Capital

277.61 Million

Editas Medicine Stock Technical Analysis

Editas Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Editas Medicine technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Editas Medicine trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Editas Medicine Period Price Range

Low
March 14, 2022
High

 15.01 

  

 14.08 

-0.93-6.2%

Editas Medicine March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Editas Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Editas Medicine shares will generate the highest return on investment. By undertsting and applying Editas Medicine stock market strength indicators, traders can identify Editas Medicine entry and exit signals to maximize returns

Editas Medicine Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Editas Medicine's price direction in advance. Along with the technical and fundamental analysis of Editas Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Editas to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Editas Medicine is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Editas Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Editas Medicine Stock. Highlighted below are key reports to facilitate an investment decision about Editas Medicine Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Editas Medicine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Editas Stock please use our How to Invest in Editas Medicine guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Editas Stock analysis

When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Editas Medicine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Editas Medicine. If investors know Editas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Editas Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.02)
Revenue Per Share
1.028
Quarterly Revenue Growth
8.187
Return On Assets
(0.21)
Return On Equity
(0.43)
The market value of Editas Medicine is measured differently than its book value, which is the value of Editas that is recorded on the company's balance sheet. Investors also form their own opinion of Editas Medicine's value that differs from its market value or its book value, called intrinsic value, which is Editas Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Editas Medicine's market value can be influenced by many factors that don't directly affect Editas Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Editas Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Editas Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Editas Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.